ACE inhibitors Flashcards

1
Q

Mechanism of action

A

Inhibit angiotensin-converting enzyme which results in the relaxation and widening of blood vessels - this lowers BP and improves blood flow to the heart muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Choice of ACEi to prescribe depends on

A
  • Pt comborbidities
  • Local recommendations
  • Cost
  • Where possible, prescribe a drug that is only taken OD
  • Where possible, prescribe non-propietary drugs where appropriate and minimise cost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contraindications

A
  • PHx angio-oedema associated with previous exposure to ACEi
  • Hereditary or recurrent angio-oedema
  • Diabetes mellitus or eGFR <60, who are also taking aliskiren
  • Pregnant and those planning pregnancy due to risks to fetus
  • Breastfeeding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

A patient has become pregnant. She is taking an ACEi. What should you do?

A

Ideally stop treatment with ACEi as soon as pregnancy is detected
If appropriate, start alternative treatment
1st line labetolol, if not then nifedipine MR, if not then methyldopa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why should ACEi not be taken if breastfeeding

A

Not recommended as there is limited info on safety in breastfeeding women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cautions

A
  • Black African/Caribbean origin, or primary aldosteronism (may respond less well)
  • Renal impairment (hyperkalaemia & other adverse effects more common, may need dose reduction)
  • Diuretics
  • Diabetes (increased risk of hyperkalaemia, may reduce BG)
  • Hypertrophic cardiomyopathy or aortic or mitral valve stenosis
  • Peripheral vascular disease or generalised atherosclerosis (risk of silent renovascular disease)
  • Severe or unstable heart failure (initiate under specialist supervision only)
  • Severe or asymptomatic aortic stenosis (risk hypotension)
  • Collagen vascular disease (possible increased risk agranulocytosis; blood counts recommended)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Which people are more likely to experience first-dose hypotension?

A
  • High dose diuretics
  • Low sodium diet
  • On dialysis
  • Dehydrated
  • Cerebrovascular disease
  • Ischemic heart disease
  • Heart failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Advice to patients taking their first dose

A
  • Take first dose in evening to avoid feeling dizzy from first-dose hypotensive effect, then if the drug is well-tolerated, future doses can be taken in the morning
  • Advice not featured in BNF or info from manufacturers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Who will require low starting doses of ACEi?

A

People more prone to adverse effects
- elderly
- frail
- renal impairment
- low-dose diuretics (e.g. bendro 2.5mg OD)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Who will need to be referred to secondary care to initiate ACEi drug therapy? (diuretics)

A

People who are taking high dose diuretics (more than 80mg furosemide or equivalent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

When should ACEi be initiated in secondary care, under specialist supervision and careful clinical monitoring

A

○ Severe heart failure
○ Receiving multiple or high -dose diuretic therapy (e.g. more than 80mg furosemide or equivalent)
○ Receiving concomitant ARB or aliskiren
○ Hypovolemia
○ Hyponatraemia (plasma sodium lese than 130mmol/L)
○ Hypotension (systolic BP below 90)
○ Unstable heart failure
○ Haemodynamically significant LV Inflow or outflow impediment (e.g. stenosis of aortic or mitral valve)
○ High dose vasodilator therapy
○ Known renovascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

You observe that a patient has had an increase in their serum creatinine and potassium after starting ACEi/having had an increased dose

A

Some increase in serum creatinine and potassium is expected! Different levels will require different steps

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What to do if a patients eGFR has decreased by <25% or serum creatinine has increased by <30%

A

○ Do NOT modify ACEi dose
○ Recheck levels in another 1-2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What to do if a patients eGFR has decreased by 25% or more, or serum creatinine has increased by 30% or more

A

○ Investigate other causes of deteriorating renal function (e.g. volume depletion)
○ Consider concurrent meds which could contribute to deterioration in renal function, and stop or reduce the dose where possible
§ Nephrotoxic drugs (e.g. NSAIDs)
§ Vasodilators (e.g. CCB, nitrates)
§ Potassium supplements or potassium-sparing diuretics
§ Diuretics (consider dose reduction if pt hypovolaemic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What to do if a patients eGFR has decreased by 25% or more, or serum creatinine has increased by 30% or more , and this persists despite having taken measures (e.g. investigating other causes of deteriorating renal function such as volume depression, and considering and reviewing other concurrent meds they are taking that can contribute to decline in renal function)

A
  • Stop ACEi .. OR
  • Reduce dose to previously tolerated lower dose and recheck levels in 5-7 days (add an alternative antihypertensive med if required)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

A patient has serum potassium levels of 5.0mmol/L or above. What do you do?

A

○ Investigate other causes of hyperkalaemia and treat accordingly
○ Stop or reduce dose of K-sparing diuretics (amiloride, triamterene, spironolactone) or nephrotoxic drugs (e.g. NSAIDs)

17
Q

A patient has serum potassium levels that persist between 5.0-5.9mmol/L despite having taken measures such as investigating other causes of hyperkalaemia and treating them, and stopping or reducing the dose of K-sparing diuretics. What do you do?

A

Reduce dose of ACEi to previously tolerated lower dose and recheck levels in 5-7 days

18
Q

If serum K+ persists above 6mmol/L despite having taken measures to fix this (e.g. considering and treating other causes of hyperkalaemia, stopping or reducing the dose of K-sparing diuretics, reducing dose of ACEi). What do you do?

A

STOP ACEi

19
Q

why are they cautioned in diabetes

A

may lower GC; increased risk of hyperkalaemia

20
Q

common SE

A

alopecia
angina
angioedema (may be delayed, more common in black)
arhythmias
dizziness
electeolyte imbalance
RI
diarrhoea etc

21
Q

why should ACE be stopped if marked elevation of hepatic enzymes or jaundice

A

reports of choelstatic jaundice, hepatitis, fulminant hepatic necrosis, liver failure

22
Q

ramipril max dose if HI

A

2.5mg daily

23
Q

ramipril max doses in renal impairment

A

5mg if CrCl 30-60
initially 1.25mg if CrCl <30, and do not exceed 5mg daily

24
Q

Examples of ACEi

A

End in -pril e.g. enalapril, ramipril, lisinopril